End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer

BACKGROUND: In men undergoing definitive radiation for prostate cancer, it is unclear whether early biochemical response can provide additional prognostic value beyond pre-treatment risk stratification. METHODS: Prostate cancer patients consecutively treated with definitive radiation at our institut...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Prostate Cancer Prostatic Dis
Autors principals: Narang, Amol K., Trieu, Janson, Radwan, Noura, Ram, Ashwin, Robertson, Scott P., He, Pei, Gergis, Carol, Griffith, Emily, Singh, Harleen, DeWeese, Tate A., Honig, Stephanie, Annadanam, Anvesh, Greco, Stephen, DeVille, Curtiland, McNutt, Todd, DeWeese, Theodore L., Song, Daniel Y., Tran, Phuoc T.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5429233/
https://ncbi.nlm.nih.gov/pubmed/28094250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2016.67
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars